Genetic Abnormalities in MALT Lymphoma
Genetic Abnormalities in MALT Lymphoma
批准号:
17590311
负责人:
INAGAKI Hiroshi
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
点击翻译按钮获取中文摘要
英文摘要
MALT lymphoma is generally associated with chronic inflammation. However, some tumors are independent of chronic inflammation, and positive for API2-MALT1 fusion gene. We performed the immunoglobulin heavy chain (IgH) gene analysis of gastric MALT lymphomas, and clarified that chronic inflammation-dependent tumors often used selected VH fragments, such as VH3-23 and VH3-30. In contrast, chronic inflammation-independent tumors used variegated VH fragments. This finding suggests that these two groups may be derived from different B-cell subsets, and progression from the former to the latter may not be a common pathway (Sakuma H, et al. Mod Pathol 2007). Thymic MALT lymphomas are closely associated with autoimmune disease. We analyzed these rare tumors for the IgH gene usage and found that they used VH fragments similar to those used in chronic inflammation-dependent gastric MALT lymphomas (Yoshida M, et al. J Pathol 2006). These data suggest that MALT lymphomas closely associated with ch … More ronic inflammation show restricted usage of VH fragments, and these tumors are genetically different from MALT lymphomas independent of chronic inflammation. Silencing of p16 gene has been associated with lymphoma progression. We analyzed p16 gene silencing in pulmonary MALT lymphomas and its clinicopathological significance. p16 gene was already silenced, mainly by gene hypermethylation, in many of the tumors at diagnosis, and this silencing was not correlated with any clinicopathological factors. This finding suggests that p16 gene silencing is associated with lymphomagenesis rather than lymphoma progression (Takino H, et al. Mod Pathol 2005). MALT lymphoma comprises up to 90% of primary pulmonary lymphomas, but its diagnosis is often difficult. API2-MALT1 fusion is specific to MALT lymphoma, and is detected in nearly half of the pulmonary cases. We performed a multiplex RT-PCR assay and successfully detected the fusion transcript using archival cytological specimens (BAL, sputum, and pleural effusion). Detection of API2-MALT1 fusion in these specimens would be useful as an ancillary assay for the diagnosis, staging, and follow-up of pulmonary MALT lymphoma (Inagaki H, et al. Int J Hematol 2005). We reported a case of oral MALT lymphoma that showed spontaneous regression (Sakuma H, et al. Pathol Int 2006), and cases that showed occurrence of diffuse large B-cell lymphomas after H. pylori eradication for MALT lymphomas (Iwano M, et al. Am J Gastroenterol 2006). Less
期刊论文(47)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
The MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma
MECT1-MAML2 融合转录本定义了粘液表皮样癌的有利子集
DOI:
--
发表时间:
2006
期刊:
Clin Cancer Res 12
影响因子:
--
作者:
[Okabe M, Inagaki H, et al.]
通讯作者:
et al.
Immunoglobulin VH gene analysis in primary gastric MALT lymphomas
原发性胃MALT淋巴瘤免疫球蛋白VH基因分析
DOI:
--
发表时间:
2007
期刊:
Mod Pathol 20
影响因子:
--
作者:
[Sakuma H, Inagaki H, et al.]
通讯作者:
et al.
Immunoglobulin V_H genes in thymic MALT lymphoma are biased toward a restricted repertoire and frequently unmutated
胸腺 MALT 淋巴瘤中的免疫球蛋白 V_H 基因偏向于受限的基因库并且经常未突变
DOI:
--
发表时间:
2006
期刊:
J Pathol 208
影响因子:
--
作者:
[Yoshida M, Inagaki H, et al.]
通讯作者:
et al.
DOI:
10.1111/j.1349-7006.2006.00345.x
发表时间:
2007-01-01
期刊:
CANCER SCIENCE
影响因子:
5.7
作者:
[Kojima, Masaru, Inagaki, Hiroshi, Nakamura, Shigeo]
通讯作者:
Nakamura, Shigeo
DOI:
10.1186/1471-230x-6-25
发表时间:
2006-09-12
期刊:
BMC GASTROENTEROLOGY
影响因子:
2.4
作者:
[Takahashi, Hiroki, Sawai, Hirozumi, Manabe, Tadao]
通讯作者:
Manabe, Tadao
共 24 条
Practice of Engineering Design Education and Regional Cooperation Education Through Programming Education
-
批准号:16K00987
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2016
-
负责人:INAGAKI Hiroshi
-
依托单位:
the transition of "Yi-ming" image at the dynasty alternations in China
-
批准号:16K02595
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.08万
-
财政年份:2016
-
负责人:INAGAKI Hiroshi
-
依托单位:
Molecular Pathology of Mediastinal Lymphoproliferative Disoders of the Adult
-
批准号:24590422
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2012
-
负责人:INAGAKI Hiroshi
-
依托单位:
Development of Learning Tools for Early Engineering Education aiming at being High-Level ICT Staff and Construction of Evaluation System for Education Program
-
批准号:22500831
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.16万
-
财政年份:2010
-
负责人:INAGAKI Hiroshi
-
依托单位:
Significance of microRNA in T-cell malignancies
-
批准号:21590377
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2009
-
负责人:INAGAKI Hiroshi
-
依托单位:
Molecular pathology and classification of MALT lymphoma
-
批准号:19590359
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:INAGAKI Hiroshi
-
依托单位:
Oncogenesis and clinicopathologic characteristics of MALT lymphoma
-
批准号:15590310
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2003
-
负责人:INAGAKI Hiroshi
-
依托单位:
Molecular and Clinicopathologic Significance of Gene Alteration Associated with MALT Lymphoma
-
批准号:13670185
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2001
-
负责人:INAGAKI Hiroshi
-
依托单位:
ANALYSIS OF ABNORMAL GENES ASSOCIATED WITH SYNOVIAL SARCOMA ONCOGENESIS.
-
批准号:11670185
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1999
-
负责人:INAGAKI Hiroshi
-
依托单位: